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Running title:  Psychological factors in chronic oedema (CO): A case- control 
study 
 
Abstract 
 
Objective:  To examine psychological health and perceived social support in patients 
with chronic oedema (CO). 
 
Methods: A random sample of patients who had been previously identified within a 
chronic oedema (CO) service in an urban area of south west London were group 
matched for age and gender with community controls in a case control study.  
 
Results: One hundred and seven cases and 102 controls (women 82%) were 
identified. CO was caused by cancer or its treatment in 51 (48%) of cases and 
affected the leg in 65 (61%); the arm 41(38%) and the limb and midline in 15 (14%).  
Length of time with CO was long with 50 (47%) suffering for > 10 years. Cases were 
more likely to be single or divorced/separated (p=0.041) and have reduced mobility 
(p <0.001).   
 
SF36 scores showed cases had significantly poorer overall HRQOL in particular: 
physical functioning (p=0.003); role physical (p<0.001) general health (p=0.026); 
vitality (p=0.015); social function (p=0.007) and role emotional (p=0.041). EQ5D 
health index scores were significantly reduced in cases by 13 points (P= <0.001, 95% 
CI 5.8, 21.6) compared with controls with a similar pattern for the VAS scale (p<0.00 
95% CI 7.6, 17.1).  
 
The MOS scale showed cases had similar size social networks to the control group 
(5.8/6.6 p=0.49) but had lower total perceived social support scores (67.8/76.1 p= 
0.018).Cases had reduced support in all 5 domains with tangible and affectionate 
support significantly reduced for cases compared to controls.  
 
Cases used significantly fewer coping strategies (COPE scale) than controls with 
regard to: active coping (p=0.024); planning (p<0.001) and use of instrumental 
support (p=0.006). Significantly higher levels of coping were used by cases for the 
following domains: restraint (p=0.031), positive reinterpretation and growth (p<0.001); 
acceptance (<0.001); denial (p<0.001); mental disengagement (p<0.001); 
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behavioural disengagement (<0.001): substance abuse (p=0.010) and humour 
(p<0.001).  
   
Conclusions: Patients with CO have poorer health and greater impact on many 
aspects of HRQOL. While the size of social networks they report appear preserved, 
the levels of perceived social support are reduced. The pattern of use of coping 
strategies was complex with evidence of reduced problem solving combined with 
enhanced emotion focused coping such as acceptance and reinterpretation 
indicating illness adjustment. Deficits in the ability to function socially combined with 
perceived reduction in support and reduced mental health and emotional scores 
within the SF36 scale indicate the risk of developing psychological issues such as 
depression. Systems of care should offer an environment to address these issues. 
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Introduction 
 
Chronic Oedema - an overview. 
 
The term chronic oedema is now used interchangeably with the term Lymphoedema 
to describe swelling present for more than 3 months and arising from the 
accumulation of fluid and other tissue elements that would otherwise drain via the 
lymphatic system (1).  It can be a grossly disfiguring condition, usually affecting the 
limb, which causes discomfort, functional disability and symptoms such as pain. It 
can be complicated by recurrent infections often requiring hospital admission.  
Untreated, limbs can become huge, and the term elephantiasis illuminates their 
appearance. Recent research has shown that it affects many different patient 
populations and that people are found throughout the health systems (1)(2) . The 
cause of chronic oedema is often complex and includes: damage to lymphatics 
during cancer treatment, primary lymphoedema (due to problems in the development 
of the lymphatic system); damage to the venous system (phlebo-lymphoedema) and 
obesity (3),(4),(5),(6). It occurs in those with chronic diseases affecting mobility such as 
spina bifida, multiple sclerosis and rheumatoid arthritis and in cardiovascular 
diseases (7)(8)(9)(2)  . The prevalence is highest in the elderly with risks factors including 
obesity and reduced mobility, both of which are continuing to increase in western 
health care populations (1)(2).  Evidence from studies in cancer populations with CO 
indicates that the impact on health related quality of life is high (10)(11)12(13)(14). Other 
psychosocial issues have received scant attention in patients with primary 
lymphoedema and within the heterogeneous patients affected with chronic oedema 
(15). 
 
The emphasis of treatment is on helping the patient to achieve as much self-
sufficiency and independence as possible, given the chronic nature of their condition, 
and to reduce the incidence of co-morbidity and the need for intensive therapy and 
hospitalisation (16). Treatment may involve an intensive phase (decongestive 
lymphatic therapy-DLT) that reduces the oedema.  Methods include appropriate skin 
care, manual lymphatic drainage (MLD), multi-layer lymphoedema bandaging 
(MLLB), and isotonic exercise.  The second phase of maintenance therapy may 
include self -bandaging, compression hosiery, exercise regimens, skin care and self-
administered massage. Surgery and liposuction are used in selective cases but all 
require an element of patient self- management (17). Drug therapy options are 
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currently of limited use except in selective cases (18).   
 
Psychosocial issues and Chronic Oedema   
 
There is increasing recognition of the role that psychological status plays in the 
development and outcomes of chronic disease, but little understanding of its 
importance in CO. Much of the quality of life research has been undertaken in 
patients following cancer, with a predominant focus on breast cancer related 
Lymphoedema (11)(19)(20).  This has highlighted the significant impact on emotional 
state, social isolation, reduced functional status and symptoms such as pain. Other 
issues such as the effects on body image and the ability to connect within the social 
environment and local culture have also been highlighted [21, 22}. All of these factors 
may affect long term psychological health. 
 
Reliance on data drawn from specific patient groups fails to identify the impact in the 
wider range of patients. It is essential to understand the clinical, psychological and 
economic burden in order to negotiate for improved funding for this patient group in 
an increasingly challenged health care system. This study was designed to address 
this and by including a control group compare the additional burden of the disease.  
 
Changing Psychosocial Burden  
Patients with CO often have complex co-morbidities with the potential to develop 
significant physical disability.  As illness complexity increases, so may the 
psychological impact with the risk of problems such as depression, anxiety and social 
isolation.  Treatment has followed a traditional medical model that focuses on 
reducing tissue oedema and stabilising skin changes, Very little attention has been 
placed on identifying and treating psychological problems or understanding the daily 
challenges faced by patients, families and carers (23)(24)(25).  There has been some 
attempt to de-medicalise management with the development of patient support 
groups (26). 
 
 
 Coping, social support and health outcomes. 
The link between coping, social support and health outcomes is well established 
(27)(28). Epidemiological studies for decades have shown that patients with 
cardiovascular disease show (though not always consistently) increased mortality in 
those who are socially isolated and decreased in those with good levels of support 
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(29). There are a number of studies reporting an association between low social 
support and high levels of stress and negative health outcomes (30)(31)(32). 
 
Access to social support has been found to be significantly associated with positive 
rates of recovery in a range of conditions such as myocardial infarction (33)(34)(35).  
Burn victims reported higher self-esteem and general satisfaction if they were 
receiving good social support (36). A study of patients with hypertension found that 
social support was linked to better blood pressure control and maintenance (37), and 
patients with kidney disease were found to have higher morale if they were within a 
supportive, cohesive family (38). Finally, a study of 110 patients with chronic 
obstructive airways disease (39) identified that social support was linked to both the 
functional improvement of patients as well as survival.     
 
Coping and Social support in Chronic Oedema  
There is a paucity of literature on coping and the social support needs of patients 
with CO, and much of what there is comes from the breast cancer literature. (40)(41)(42). 
What is apparent, however, is that the psychosocial effects of such a chronic, 
outwardly disfiguring and restricting condition can be profound.  
 
Studies have shown that women who develop the condition following breast cancer 
treatment exhibit higher levels of psychological, social, sexual and functional 
morbidity than women who do not (43).  Women who have poor social support, pain, 
CO in the dominant hand and/or a passive and avoidant coping style report the 
highest level of disability (43). The literature points to the importance of widening our 
understanding of the psychosocial impact of CO by evaluating the place of coping 
and perceived social support. 
 
 
Chronic oedema and health related quality of life 
Health related quality of life is a concept developed in an attempt to capture the 
impact of health and illness on a patient's physical and mental well-being as well as 
looking at the ability of the patient to function socially (44). The emphasis is on the 
patient's own perception of their health and how illness impacts on all aspects of 
daily living and the relationship of the individual within their social environment. (45).  
 
The important point is that the severity of a condition is no longer defined solely 
according to clinical criteria.  Assessment of health related quality of life, as a 
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subjective experience of the patient is a key consideration and will vary across age 
groups. For example the impact of the condition on employment, job prospects and 
relationships will perhaps be important to younger patients, while mobility and 
concurrent illness might have greater influence on how older patients perceive their 
quality of life. 
 
In 2002 the King’s Fund awarded a grant to develop and evaluate a model of care for 
patients with all forms of CO. The aim of this project was to develop, implement and 
evaluate health service and patient outcomes using an appropriate model of care 
within a London-based primary care trust (PCT).  The work included undertaking a 
psycho-social case control study. The results are now reported. 
 
The study set out to examine the following hypotheses: 
 
 Patients with CO would have generally poorer psychosocial status, higher levels 
of disability and reduced health related quality of life compared to group matched 
controls drawn from representative general practitioner lists. 
 Patients with CO would have small social networks and lower perceived  social 
support 
 Patients would use passive/avoidant coping styles and mental and behavioural 
disengagement strategies compared to controls  
 
Study Aim 
To investigate the association between coping styles, levels of social support and 
health related quality of life in patients with CO compared to a community based 
control population. 
 
Methods 
Study Design 
Case identification and controls   
The general methods for the identification of patients in this study are provided in a 
separate publication (46 in press).  In summary, all patients with chronic oedema were 
identified through primary and secondary health services and offered treatment for 
their CO within a new service in south west London (UK). Following the case 
ascertainment 312 patients were identified and from this a random sample of patients 
were drawn stratified by age, gender and site of swelling.  Cases were group 
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matched to control subjects drawn from six GP age sex registers within the 
catchment area.  Group matching occurred for gender and age. Medical notes of all 
controls were screened at entry for CO and if a positive history was given they were 
excluded and replaced.  Controls were contacted by a letter from their GP inviting 
them to attend the interview.  Those who did not wish to take part, failed to attend the 
appointment or when screened were found to have CO at the interview were 
replaced by new controls. The format of the interviews was identical for both cases 
and controls and they were undertaken by the same researcher. The analysis was 
undertaken by group matching rather than on an individual basis. This allowed for the 
slight difference in the number of cases (107) and controls (102). 
 
Patients were offered a choice of venue for the interview including their home or a 
health facility.  The data collection tools included the following  domains: (I). 
demographics , (II) clinical details, site of CO, complications and mobility status and 
(III) Psychosocial questionnaires  (EQ-5D, SF36, MOS Social Support Survey, COPE 
scale ). Where standard questionnaires were included the instructions for completion 
were followed wherever possible. Patients and controls who could complete the 
questionnaires did so. Those who were unable to do so due to poor vision were 
assisted in the process.   
 
The study was supported by a steering group of relevant experts including patients 
and carers. The data collection tools were piloted and amended with 5 patients prior 
to adaption and use. Ethical approval was obtained from the local Independent 
Ethics Committee (IEC) and the study was performed in accordance with the 
guidelines of the Declaration of Helsinki (47), and the principles of Good Clinical 
Practice (GCP) ICH E6 and EN540 standards (48). 
 
Patient Recruitment and Inclusion Criteria  
Patients were sequentially recruited to the study over a 15 month period following 
their identification and referral for treatment. The following inclusion and exclusion 
criteria were used:   
Inclusion  
 Patients with confirmed chronic oedema of > 3 months affecting the limbs 
and/or the trunk irrespective of the underlying cause  
 Patients able to understand the study and give written informed consent  
Exclusion  
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 Patients with advanced or terminal cancer 
 Patients who were unable to speak English or complete the questionnaires  
 Patients unable to give written informed consent.  
 
 
Data collection tools  
A range of validated HRQoL and psychosocial tools were used in order to fulfil the 
objectives of the study. 
The MOS short form 36 (SF-36)   
The SF36 was chosen as a generic tool to assess health related quality of life 
because it has been used in other Lymphoedema populations (49) This is a well 
validated tool that provides estimates of eight health concepts, these being; physical 
functioning (PF), Role functioning-physical (PF), bodily pain (BP); general health 
(GH); vitality (VI), social functioning (SF), role functioning-emotional (RE) and mental 
health (MH).  The responses to the 36 questions are transformed into the concepts to 
provide a scale from zero (worst possible health) to 100 (best possible health). 
 
The Euroqol (EQ5-D) 
The Euroqol (EQ5-D) was used to measure health status, the tool consists of five 
questions in the domains of mobility, self-care, usual activities, pain and anxiety (50).  
The patients' health state is determined from the responses to these questions and 
fitted into an equation developed from a regression model.  It produces scores from -
0.59 to 1.00, the lowest score being the worst possible health state and 1.00 being 
the best.  Death is valued as zero within this scale.   In addition, participants are 
asked to rate their health on a scale from zero to 100.  
 
The COPE scale 
The COPE scale was used to assess coping, (51). It was chosen because it is a 
theoretically devised and validated scale that seeks to examine the multi-dimensional 
nature of coping and has been used in different chronic illness populations. The tool 
was designed to overcome the simplistic view that coping could be divided into 
problem focussed and emotion focussed coping. The tool has been validated as a 
situational (a real life event) as well as a dispositional tool (a generalised response to 
stressful events). This is particularly important in this study in which a control 
population was being examined.  
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The COPE scale consists of 13 separate domains including five subdivided as 
problem focused (active coping; planning; seeking instrumental support; suppression 
of competing activities and restraint coping) and five as emotion focused (positive 
reinterpretation and growth; acceptance; focus on venting emotion and denial). 
Further domains are (mental disengagement; behavioral disengagement; alcohol; 
seeking emotional support; humor and turning to religion.   
 
The patients with CO completed a situational-based COPE scale where they were 
asked to consider how they coped with having the condition. The control population 
completed a dispositional version of the scale. This attempts to determine how 
people respond to difficult or stressful events in their lives. 
 
The questionnaire was self administered in the study. Separate scores for each scale 
were calculated by adding the four scores from the items within each scale. The 
scores for each scale ranged from four to sixteen. The scores for each scale indicate 
the extent to which the type of coping is being used. Scores from the situational 
COPE were compared with the dispositional data from the control group to determine 
differences in the two populations.  
 
 
The Medical Outcomes Study Social Support Survey (MOS) 
Despite the plethora of social support tools that have been developed, few have been 
shown to have robust psychometric properties. This situation is compounded by the 
lack of clear conceptual agreement over what constitutes social support (52). The 
MOS has been developed in an attempt to overcome these issues. The tool is 
designed to represent the multiple dimensions of functional support: 
emotional/informational, tangible, affectionate, and positive social interaction.  
 
The MOS is divided into two sections. The first section requires the patient to number 
how many close friends and relatives that they feel at ease with and can talk to about 
what is on their mind.  This is defined as the social network measure. The second 
section involves 19 statements concerning different aspects of social support. 
Patients are required to make a response, nearest to their current experience, on a 
five-point Likert scale (None of the time - all the time). Each of the sub scales in the 
tool is scored individually. Scores are ordinally arranged with possible scores for the 
total 19 questions ranging from 19 to 95. 
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Data analysis  
Categorical data were analysed using logistic regression analysis with the dependent 
variable being the participants CO status (Case or control).  Results were reported as 
both percentages of the total in each category together with odds ratios and 95% 
confidence intervals. The level of significance was derived from the logistic 
regression result.   
 
Continuous data were analysed comparing the two groups (cases and controls). 
Results were presented as means (SD) together with mean difference and 95% 
confidence intervals. The level of statistical significance was derived from the t-test 
analysis.  
 
Bias  
Attempts to reduce bias within the study were undertaken. This included drawing a 
representative sample from the wider group for age, gender and distribution of the 
site of swelling.  Controls were drawn from the same geographical area and GP 
registers as for the cases. It is recognised that people with early chronic oedema will 
not be identified through this methods as they may not have yet presented to health 
professionals therefore the patients will be more severe than the total population 
affected.  
 
Dealing with missing data 
Due to the frailty of some of the patients not all questionnaires were completed. This 
is reflected in the presentation of results in which the number of cases and controls 
completing the questions are identified within the tables.  Health related quality of life 
results were adjusted for age and gender,  
 
Results  
From the main case ascertainment through health services 312 patients who fulfilled 
the criteria for chronic oedema were identified.  In order to reach the required sample 
of 107 cases, 120 people were required to be screened. The results for the cases 
and controls are presented in Fig 1. The main reason for non -selection for cases 
was failure to attend appointments or an unwillingness or inability to participate in the 
study. Cases were replaced according to the stratification until the sample was 
completely recruited. A similar procedure was used for controls in addition to 
screening for previous chronic oedema. The reasons for non-inclusion were similar to 
the cases. A total of 128 controls were screened to achieve the control sample.  
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Within the sample of cases (n=107), 88 (82%) were women. The mean (sd) age was 
72.9 years in men and 68.6 years in women. Within the sample 77 (75%) were older 
than 70 years and 27 (25%) greater than 80 years. Only 27(25%) were under the age 
of 60. As expected given the age of the sample most people were retired (78%) with 
an additional 4.7% not working due to illness. 
 
Chronic oedema affected the leg in nearly two thirds (65 (61%) with 41(38%) having 
arm swelling and a further 15(14%) having both midline swelling in addition to the 
limbs being affected. Cancer or its treatment was the cause of CO in 55 (52%) in 
whom 35(69%) had controlled cancer with only 1(2%) suffering metastatic disease. 
The swelling was of long duration with 50 (47%) suffering for more than 10 years and 
a further 54(51%) for between 1 and 10 years. Only 2(2%) had swelling for a short 
period (3 to 11 months). Cellulitis episodes occurred in 22 (21%) cases of whom 5 
(5%) required hospital admission.  
  
There were significant differences in the marital status of cases and controls (p= 
0.041). More cases were single (19) or divorced or separated (18) compared to 
controls (11/8) (p=0.041).  No statistically significant difference was found in the living 
status between cases and controls although more cases were likely to live with a 
relative or companion (15/10) (p= 0.64).  Cases had significant deficits in mobility 
with many confined to a chair or requiring a walking aid to achieve any level of 
mobility. The mobility status of the control group was significantly better 
(68/36)(p<0.001). 
 
 
SF36 
Results from the SF36 reveal significant deficits in the HRQoL scores in cases 
compared with the control group (table II). In particular deficits were seen in physical 
functioning (p=0.003), role physical (p<0.001), general health (p=0.026), vitality (p= 
0.015), social function (p=0.007) and role emotional (p=0.08). However all other 
domains were reduced and approaching a standard level of significance.  
 
EQ5D  
EQ5D health index scores were significantly reduced in cases by 13 points compared 
with controls (79/66 p<0.001).  Results from the VAS scale show a similar difference 
64/76 (<0.001). The mobility questions confirmed the significant impact on mobility 
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with 68 (64%) of cases stating they had problems with walking or were confined to a 
wheelchair or bed compared to only 36(36%) of the controls (p<0.001). 
 
MOS Social Support Survey 
The number of people within the social networks of cases and controls were similar 
(5.8/6.6) (P=0.49). The total scores for cases (67.8) were significantly lower than for 
the controls (76.1) suggesting an overall lower perceived social support (p=0.018). 
Table IV shows that cases reported reduced social support for all the scales except 
for emotional/ informational support (p= 0.09) and positive interaction (p=0.07) both 
of which were approaching a standard level of statistical significance.  
 
COPE scale 
Results from the COPE scale indicate that the patients used less problem and 
emotion focused coping strategies than the control group (table V). Cases used 
significantly fewer coping strategies than controls with regard to: active coping 
(p=0.024); planning (p<0.001) and use of instrumental support (p=0.006). 
Significantly higher levels of coping were used by cases for the following domains:  
restraint (p=0.031), positive reinterpretation and growth (p<0.001); acceptance 
(<0.001); denial (p<0.001); mental disengagement (p<0.001); behavioural 
disengagement (<0.001):  substance abuse (p= 0.010) and humour (p<0.001). 
Religious coping strategies were similar between groups (p=0.56). 
 
Discussion 
The results from this study would indicate that CO is associated with significant 
psychosocial morbidity. The demographic data from the cases confirmed that this 
was a predominantly elderly population who had been suffering with chronic oedema 
for a long period with less than half having CO as a consequence of cancer or its 
treatment. The proportion of women was high and there was evidence of significant 
impact on mobility.  General health status was poor with a 13 point difference in 
EQ5D scores compared to controls.  Elderly populations will experience a range of 
chronic diseases however the control group report an improved health profile 
suggesting that the patients with CO have a complex array of medical conditions 
resulting in swelling that is impacting on many aspects of life.  
 
The study found substantial deficits in HRQoL and confirmed the first study 
hypothesis that patients with CO would have generally poorer psychosocial status, 
higher levels of disability and reduced health related quality of life compared to 
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GP/age/sex group matched controls drawn from representative general practitioner 
lists. The controls were drawn from the same geographical population at the same 
time. The differences observed therefore cannot be explained by temporal or regional 
differences between the two groups. Incorporation of a control group into this study 
has strengthened the understanding of the magnitude of the effect of CO compared 
with people of similar age and gender.  Results from the EQ5D scores indicated the 
cases had significant health deficits. In a study to define utilitiy scores in 277 patients 
with different causes of lymphoedema using the EQ5D scale the lowest scores 
occurred for those with lower limb CO secondary to cancer with the greatest in those 
with severe swelling and a high BMI. The EQ5D scores indicate a worse health 
status than in other published studies who report a mean score in the range of 80 
compared to 66 in the current study (53). 
  
The second study hypothesis was that patients with CO would have small social 
networks and lower perceived social support. This has been partially supported with 
cases indicating low levels of social support however the size of the social networks 
were similar to the control group. Patients with poor psychosocial support available 
and low levels of information have been found to have high levels of anxiety and 
depression (54).  In this study cases had significantly lower levels of perceived support 
than the controls, suggesting that this may be an influencing factor.  High levels of 
depression have consistently been associated with passive patient behaviour such 
as non- adherence to therapy (55).   
 
The results from the COPE questionnaire support the third study hypothesis that 
patients with CO would use more passive/avoidant coping styles and mental and 
behavioural disengagement strategies compared to controls.  The overall pattern of 
results suggests that the patients with CO who completed a questionnaire based on 
their current experience, used fewer coping strategies than the control group who 
completed the dispositional version of the tool. It is not possible to determine how 
much the perceived differences can be explained by the use of a situational 
questionnaire in patients who are experiencing a real situation compared to those 
who are asked to make a judgement about how they generally cope with stressful 
situations.. The control group may be over predicting the use of coping strategies that 
they believe they would use. In addition, the patients were all at different points in 
their illness experience. Evidence from the coping research has shown that patients 
with chronic illness tend to use more emotion focused strategies than problem 
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focused (56). Patients may have undergone considerable adaptation which is 
influencing the pattern of coping strategies they use. 
 
Little research has been undertaken to determine how patients cope with their CO 
with some evidence from the breast cancer population of a complex pattern of usage 
with men showing lower coping scores (57). Those with melanoma and CO affecting 
the leg had worse quality of life and lower coping scales compared to those in whom 
the tumour was on the arm (58). In a qualitative study of leg ulcer patients, Walshe 
described how patients used strategies which sought to normalise their condition in 
order to cope with the relentless demands of their condition and treatment (59).  Four 
main strategies were identified: coping by comparison, coping by feeling healthy, 
coping by altered expectation and coping by remaining positive.  
 
The outcome of individual coping strategies on symptoms associated with CO is 
likely to be complex and to vary over time and be influenced by the disease 
trajectory. Suppression of activities that may increase the prominence of symptoms 
such as pain may be an important coping strategy that allows patients to live with 
their CO with less intrusion of symptoms and potentially with improved quality of life, 
however these may not be beneficial to overall control of oedema. Strategies such as 
exercise which may be viewed as important by professionals may be seen differently 
by patients who see no perceived benefit but do note that such activities increase 
their symptoms. This raises issues concerning how health beliefs influence the 
choice of coping strategy. It reinforces the issue that coping must be viewed flexibly 
and that the relevance of individual coping strategies may be influenced by many 
factors, not least the stage and severity of the patient’s illness.  
 
Patients appear to be using a similar pattern of coping to those found in other chronic 
illness populations, and strategies that may be considered more maladaptive such as 
use of alcohol, drugs and continuous periods of mental disengagement and denial 
were used in moderation (32). 
 
 The results would suggest that the patients are socially isolated. It is not possible to 
determine whether the social isolation is a result of reduced social support or a 
consequence of the condition, which has been shown in other chronic illnesses. It 
could also be speculated that the patients are voluntarily withdrawing from social 
contact because they are aware of people’s reaction to their condition. The 
debilitating long term effects of symptoms such as pain may also be influencing their 
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desire for social interaction. Problems of mobility are severe in this patient group and 
may influence their ability to socialise if they wished to.  
 
The low levels of seeking instrumental and emotional support is evidenced despite 
the preservation of the size of their social networks. This indicates a more subtle 
effect on how people living with CO perceive support. The size of the social network 
may indicate they do not feel supported which is in turn reducing their overall quality 
of life status and increasing the perceptions of social isolation. Low levels of 
perceived support are likely to affect adherence to treatment and self efficacy and 
influence the effectiveness of the coping strategies that are adopted. These 
psychological factors in turn may influence clinical outcomes such as control of 
swelling and rates of complications such as cellulitis. For many these issues may trap 
them into a spiral of clinical and psychosocial deterioration. 
 
The role of social support in control of CO has received little research attention. In 
patient populations with wounds, many of whom have concurrent CO, there is 
increasing evidence that social support may effect health outcomes.   A number of 
studies in leg and foot ulceration report low levels of perceived support (60). In 
addition there is some evidence of an increased rate of healing in those with high 
levels of support, while those with high levels of pain and depression had reduced 
healing even when adjusted for age and underlying aetiology (60)(61).   
 
Of the 107 patients a number were unable to complete the questionnaires due to a 
range of medical and psychological issues.  It has long been recognised that these 
patients may be suffering from more extensive problems, but due to their condition 
they are unable to verbalise this.  There remains a major research challenge to 
capture the impact of their suffering.  This study was cross sectional in design, with 
patients being at different stages of their illness diathesis.  Clearly the psychological 
status may vary over time, as will their social interactions.  Tools such as the SF36 
are generic and therefore they may not identify the more subtle quality of life issues 
associated with the specific condition.  These tools also do not allow us to 
understand what the patients own expectations are about their condition, what would 
improve their sense of well being and which aspects of HRQoL they would like to see 
improved.   
 
Current research has focused on the evaluation of HRQoL and attempts to determine 
changes with treatment.  Clearly there is a need to understand in more depth the 
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aspirations of patients in order to ensure that they can function to their highest ability.  
This study would support that clinicians need to have greater awareness of 
psychological health problems in patients with CO and that services need to reflect 
the issues identified with access to psychological support to those showing distress.  
 
Limitations of the study 
This study has a number of limitations. The sample size, although reflective of the 
larger population, is relatively small. The patients recruited are likely to be complex in 
their clinical presentation. However despite this fact there is evidence that they are 
typical of the types seen in current CO services in the UK (1)(2). Many have had their 
condition for a long duration and have not had an appropriate diagnosis or treatment 
leading to deterioration and morbidity (1). As there are no agreed coding systems or 
requirements to screen for CO in primary care it is likely that many with mild CO will 
not be identified and only become apparent when complications occur. Cases and 
controls were identified in the health care system and it is acknowledge that not 
everyone in the UK is registered with a GP and that transitory populations are not 
well represented in this type of research. The study used well validated generic 
HRQoL tools, however more recently disease specific tools have been developed 
that may be more sensitive to change and should be incorporated into future 
research (66)(67). Despite this the tools adopted for the study have been able to identify 
significant differences between groups and importantly with other disease states.  
 
Conclusion  
This study has highlighted the psychological impact that CO has on patients.  There 
is a clear need to examine this in more detail particularly with respect to the 
differences experienced at varying stages of the illness trajectory and in the different 
manifestations of chronic oedema related to the array of associated medical 
conditions. The low levels of perceived support and increased levels of social 
isolation support the concept of services that allow for an integrated approach which 
includes psychological support and offers patient interaction, a relief from isolation 
and an opportunity to share common experiences. 
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Tables  
Table 1: Comparison of Demographic and Social Factors. 
Values expressed as (OR) and 95% confidence intervals generated from logistic 
regression analysis. 
 Controls 
N=102 
Cases 
N=107 
 
 
 
 
Gender No % No % OR 95% CI p-value 
Men 19 19 19 17 1.00   
Women 83 81 88 82 1.06 0.52, 2.14 0.87 
Age 
<60 27 26 27 25 1.00   
60-69 24 24 27 25 1.13 0.52, 2.42  
70-79 24 24 21 20 0.88 0.40, 1.93 0.88 
80+ 27 26 32 30 1.19 0.57, 2.48  
        
Marital Status        
Widowed 30 30 26 24 1.00   
Single 11 11 20 19 2.09 0.85, 5.18 0.041 
Married 52 51 42 39 0.93 0.48, 1.81  
Divorced/separated 8 8 19 18 2.74 1.03, 7.29  
Living status 
Lives alone 37 36 42 39 1.00   
With spouse 51 50 45 42 0.78 0.43, 1.41 0.64 
Relative/companion 10 10 15 14 1.32 0.53, 3.30  
Other 4 4 5 5 1.10 0.28, 4.41  
Mobility status (Euroqol) 
No problems walking 64 64 38 36 1.00   
Problems walking/ 
confined to bed 
36 36 68 64 3.18 1.80, 5.62 <0.001 
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Table 2:  Clinical details of the swelling 
 Cases (107)  
 N (%)  
Site of swelling 
Limb plus midline 15 (14%)  
Arm(s)  41 (38%)  
Leg (s) 65 (61%)  
Cancer cause   
No 55 (52%)  
Yes 51 (48%)  
Cancer status   
Controlled 35 (69%)  
Inactive 14 (27%)  
Metastatic  1 (2%)  
Not known 1 (2%)  
Swelling duration 
3-11 months 2 (2%)  
1-5 years 40 (38%)  
6-9 years 14 (13%)  
>10 years 50 (47%)  
   
Infection over past year 
None 85 (79%)  
One 14 (13%)  
Two 3 (3%)  
3-5 2 (2%)  
6-10 2 (2%)  
>10 1 (1%)  
Admission for infection over past year 
None 102 (96%)  
One 4 (4%)  
Two 1 (1%)  
 
Table III.  Comparison of the SF-36 between cases with CO and controls 
 Control Case  
 N Mean (sd) N Mean (sd) Difference 95%CI t (df) p-value 
         
Physical 
functioning 
102 67.6 (43.6) 107 48.9 (46.8) 18.7 6.4, 31.1 2.99 (207) 0.003 
Role physical 101 71.2 (29.1) 107 45.9 (33.3) 25.3 16.7, 33.9 5.82 (206) <0.001 
Bodily pain 101 70.2 (29.9) 107 64.0 (30.9) 6.2 -2.1, 14.5 1.47 (206) 0.14 
 20 
General health 101 67.1 (22.9) 107 59.5 (26.2) 7.7 1.0, 14.4 2.25 (206) 0.026 
Vitality 101 59.4 (21.5) 107 51.5 (24.2) 7.8 1.5, 14.1 2.46 (206) 0.015 
Social functioning 101 78.7 (31.5) 107 66.7 (32.5) 12.1 3.3, 20.8 2.71 (206) 0.007 
Role emotional 102 78.4 (39.7) 107 66.4 (44.7) 12.1 0.5, 23.6 2.06 (207) 0.041 
Mental health 101 78.1 (19.7) 107 73.3 (19.2) 4.8 -0.5, 10.1 1.78 (206) 0.077 
         
Euroqol 99 79.3 (23.5) 103 65.6 (32.7) 13.7 5.8, 21.6 3.40 (200) <0.001 
VA scale 100 76.5 (15.5) 107 64.1 (18.9) 12.4 7.6, 17.1 5.14 (205) <0.001 
 
 
Table 4. Differences in the mean MOS Social Support Survey scores (case-control). 
Values given are the mean difference, (SEM) and 95% confidence intervals, t and p-value.  
 Control Cases Case – Control    
 N Mean  SD N Mean SD Mean 
difference 
SEM 95% 
Confidence 
interval 
t-
value 
d.f. p-
value 
Emotional/ 
Informational 
96 73.5 28.8 103 66.3 31.5 7.2 4.3 -
1.3 
To 15.7 1.68 197 0.09 
Tangible 
Support 
100 81.4 24.6 100 70.3 29.1 11.1 3.8 3.5 To 18.6 2.9 198 0.004 
Positive 
Interaction 
98 73.6 28.8 105 65.6 32.4 8.0 4.3 -
0.5 
To 16.5 1.85 201 0.07 
Affectionate  
Support 
99 83.1 27.7 102 72.4 32.5 10.7 4.3 2.3 To 19.1 2.51 199 0.013 
Total 
Score 
93 76.1 25.4 95 67.8 28.6 8.3 4.0 0.5 To 16.1 2.10 186 0.018 
               
Number of 
people  
98 6.6 4.5 106 5.8 9.8 0.7 1.1 -
1.4  
To 2.9 0.68 202 0.49 
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Table 5. Differences in COPE scores (case-control). 
Values given are the mean difference, (SEM) and 95% confidence intervals, t and p-values. 
 Control Cases Case – Control    
 N Mean SD N Mean SD Mean 
difference 
SEM 95% CI t-
value 
d.f. p-
value 
 Problem Focused 
Active 
Coping 
100 10.8 2.7 103 9.8 3.2 1.0 0.4 0.1 To 1.8 2.28 201 0.024 
Planning 
 
100 10.3 3.0 102 8.7 3.5 1.6 0.5 0.7 To 2.5 3.58 200 <0.001 
Use of 
Instrumental 
social 
Support 
102 8.6 2.9 105 7.5 2.8 1.1 0.4 0.3 To 1.9 2.77 205 0.006 
Suppression of 
Competing 
activities 
101 6.5 3.2 102 6.9 3.0 -0.4 0.4 -
1.2 
To 0.46 0.92 201 0.36 
Restraint 
 
101 7.0 3.3 100 7.9 2.9 -1.0 0.4 -
1.8 
To -0.1 2.18 199 0.031 
  
Positive 
Reinterpretation 
And growth 
102 8.9 3.6 102 10.7 3.5 -1.8 0.5 -
2.8 
To -0.8 3.66 202 <0.001 
Acceptance 
 
99 8.7 4.3 104 12.2 3.1 -3.5 0.5 -
4.4 
To -2.4 6.59 201 <0.001 
Focus on 
Venting of 
Emotions 
102 7.2 3.1 103 6.8 3.0 0.4 0.4 -
0.4 
To 1.3 0.99 203 0.32 
Denial 
 
102 4.6 1.4 105 6.0 3.0 -1.4 0.3 -
2.1 
To -0.8 4.43 205 <0.001 
Mental 
Disengagement 
102 6.3 2.2 104 7.8 2.7 -1.4 0.3 -
2.1 
To -0.7 4.13 204 <0.001 
Behavioural 
Disengagement 
101 4.6 1.2 103 5.7 2.2 -1.1 0.2 -
1.6 
To -0.6 4.55 202 <0.001 
Substance use 
 
102 4.2 0.7 104 4.7 1.8 -0.5 0.2 -
0.9 
To -0.1 2.60 204 0.010 
Use of 
Emotional social 
Support 
101 6.6 3.4 105 7.1 2.9 -0.5 0.4 -
1.4 
To 0.4 1.16 204 0.25 
Humour 
 
102 5.7 2.6 104 7.8 3.3 -2.0 0.4 -
2.8 
To -1.2 4.89 204 <0.001 
Religious 
Coping 
101 8.4 5.0 102 8.8 4.4 -0.4 0.7 -
1.7 
To 0.9 0.58 201 0.56 
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